Ching-Yuan Kuo

1.6k total citations · 1 hit paper
10 papers, 948 citations indexed

About

Ching-Yuan Kuo is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Ching-Yuan Kuo has authored 10 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Ching-Yuan Kuo's work include Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Neutropenia and Cancer Infections (2 papers). Ching-Yuan Kuo is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Neutropenia and Cancer Infections (2 papers). Ching-Yuan Kuo collaborates with scholars based in Taiwan, France and United States. Ching-Yuan Kuo's co-authors include Rena Buckstein, Agnieszka Wierzbowska, Jiří Mayer, Jyh-Pyng Gau, Xavier Thomas, Farhad Ravandi, Jaroslav Čermák, Wen‐Chien Chou, Anna Dmoszyńska and Jacques Delaunay and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Lipids in Health and Disease.

In The Last Decade

Ching-Yuan Kuo

10 papers receiving 937 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

2012 818 citations Hagop M. Kantarjian, Xavier Thomas et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching-Yuan Kuo Taiwan	5	764	494	226	182	156	10	948
Susana Vives Spain	10	533 0.7×	272 0.6×	231 1.0×	152 0.8×	209 1.3×	37	791
Anna Grazia Recchia Italy	16	302 0.4×	265 0.5×	154 0.7×	151 0.8×	166 1.1×	38	653
Sujiang Zhang China	13	368 0.5×	329 0.7×	59 0.3×	223 1.2×	149 1.0×	62	710
Arlin Za United States	14	627 0.8×	266 0.5×	381 1.7×	202 1.1×	307 2.0×	28	925
Russell R. Hoover United States	10	352 0.5×	286 0.6×	51 0.2×	226 1.2×	152 1.0×	18	831
Angeline Van Orshoven Belgium	15	488 0.6×	183 0.4×	152 0.7×	291 1.6×	75 0.5×	29	735
Minenori Eguchi‐Ishimae Japan	15	351 0.5×	374 0.8×	281 1.2×	119 0.7×	101 0.6×	36	745
Mariana Emerenciano Brazil	16	312 0.4×	256 0.5×	407 1.8×	53 0.3×	82 0.5×	54	639
John Hewson Australia	13	285 0.4×	265 0.5×	137 0.6×	86 0.5×	168 1.1×	19	638
Michele Cedrone Italy	16	375 0.5×	296 0.6×	103 0.5×	237 1.3×	85 0.5×	36	620

Countries citing papers authored by Ching-Yuan Kuo

Since Specialization

Citations

This map shows the geographic impact of Ching-Yuan Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Yuan Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Yuan Kuo more than expected).

Fields of papers citing papers by Ching-Yuan Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Yuan Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Yuan Kuo. The network helps show where Ching-Yuan Kuo may publish in the future.

Co-authorship network of co-authors of Ching-Yuan Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Yuan Kuo. A scholar is included among the top collaborators of Ching-Yuan Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Yuan Kuo. Ching-Yuan Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Huang, Shang‐Yi, Tsai‐Yun Chen, Ching-Yuan Kuo, et al.. (2019). Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma. Oncology Reviews. 13(1). 377–377. 4 indexed citations

Tsai, Hui‐Jen, Shih Sheng Jiang, Wen-Chun Hung, et al.. (2017). A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients. Scientific Reports. 7(1). 11253–11253. 61 indexed citations

Seymour, J.F., Rena Buckstein, Valeria Santini, et al.. (2017). Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. Leukemia Research. 55. S67–S68. 1 indexed citations

Kantarjian, Hagop M., Xavier Thomas, Anna Dmoszyńska, et al.. (2012). Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(21). 2670–2677. 818 indexed citations breakdown →

Shih, Lee‐Yung, Ching-Yuan Kuo, Tsai‐Yun Chen, et al.. (2012). Emerging kinetics of BCR–ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leukemia Research. 37(1). 43–49. 8 indexed citations

Huang, Yung‐Cheng, Tai‐Been Chen, Chien-Chin Hsu, et al.. (2011). The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an 18F-FDG PET/CT Study in the Tropics. Lipids in Health and Disease. 10(1). 238–238. 28 indexed citations

Thomas, Xavier, Anna Dmoszyńska, Agnieszka Wierzbowska, et al.. (2011). Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML.. Journal of Clinical Oncology. 29(15_suppl). 6504–6504. 24 indexed citations

Kuo, Ching-Yuan, et al.. (1999). Bone Marrow Examinations as Final Clue to Diagnosis of Hypercalcemia: Report of Two Cases. Renal Failure. 21(1). 101–105. 1 indexed citations

Wu, Justina, et al.. (1999). Multiple myeloma presenting with a paraspinal tumor and malignant effusion: case report.. PubMed. 22(2). 293–8. 2 indexed citations

10.

Kuo, Ching-Yuan, et al.. (1991). Acute basophilic leukemia. A case report.. PubMed. 14(3). 202–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact